tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Joseph Catanzaro, 351 are a BUY (79.41%), 91 are a HOLD (20.59%).
Analyst Joseph Catanzaro, currently employed at MIZUHO, carries an average stock price target met ratio of 47.82% that have a potential upside of 34.17% achieved within 138 days. Previously, Joseph Catanzaro worked at PIPER SANDLER.
Joseph Catanzaro’s has documented 862 price targets and ratings displayed on 59 stocks. The coverage is on Healthcare, Consumer Cyclical, Industrials, Consumer Defensive sectors.
Most recent stock forecast was given on BCAX, Bicara Therapeutics Common Stock at 12-Aug-2026.
Analyst best performing recommendations are on LPTX (LEAP THERAPEUTICS).
The best stock recommendation documented was for CLVS (CLOVIS ONCOLOGY) at 4/14/2019. The price target of $21 was fulfilled within 1 day with a profit of $2.48 (10.56%) receiving and performance score of 105.62.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 08-Sep-2021
$1.75
$-0.27 (-13.37%)
2 years 1 months 15 days ago
(27-Aug-2024)
1/4 (25%)
$0.07 (4.17%)
2
Buy Since 12-Jan-2022
$1.5
$-0.52 (-25.74%)
2 years 1 months 21 days ago
(21-Aug-2024)
0/2 (0%)
$-0.05 (-3.23%)
Hold Since 14-May-2024
2 years 1 months 21 days ago
(21-Aug-2024)
0/5 (0%)
$37.88 (532.02%)
Buy Since 18-Apr-2018
$49
$46.98 (2325.74%)
4 years 10 months 11 days ago
(01-Dec-2021)
0/3 (0%)
$28.91 (143.90%)
Buy Since 24-Nov-2021
$49
$46.98 (2325.74%)
4 years 10 months 11 days ago
(01-Dec-2021)
1/2 (50%)
$28.91 (143.90%)
32
Which stock is Joseph Catanzaro most bullish on?
Which stock is Joseph Catanzaro most reserved on?
What Year was the first public recommendation made by Joseph Catanzaro?
